[1] Huang S, Wu S, Ding J, Lin J, Wei L, Gu J, He X. Mi-croRNA-181a modulates gene expression of zinc finger family members by directly targeting their coding regions. Nucleic Acids Res, 2010, 38(20): 7211–7218. <\p>

[2] Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modu-late hematopoietic lineage differentiation. Science, 2004, 303(5654): 83–86. <\p>

[3] Zhang Q, Sun H, Jiang Y, Ding L, Wu S, Fang T, Yan G, Hu Y. MicroRNA-181a Suppresses Mouse Granulosa Cell Proliferation by Targeting Activin Receptor IIA. PLoS ONE, 2013, 8(3): e59667. <\p>

[4] Liu L, Wang Y, Fan H, Zhao X, Liu D, Hu Y, Kidd AR, Bao J, Hou Y. MicroRNA-181a regulates local immune balance by inhibiting proliferation and immunosuppres-sive properties of mesenchymal stem cells. Stem Cells, 2012, 30(8): 1756–1770. <\p>

[5] Dahlhaus M, Schult C, Lange S, Freund M, Junghanss C. MicroRNA 181a influences the expression of HMGB1 and CD4 in acute Leukemias. Anticancer Res, 2013, 33(2): 445–452. <\p>

[6] Zhu HY, Liu MY, Hong Q, Zhang D, Geng WJ, Xie YS, Chen XM. Role of microRNA-181a in the apoptosis of tubular epithelial cell induced by cisplatin. Chin Med J (Engl), 2012, 125(3): 523–526. <\p>

[7] Chen G, Zhu W, Shi D, Lü L, Zhang C, Liu P, Hu W. Mi-croRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2. Oncol Rep, 2010, 23(4): 997–1003. <\p>

[8] Ouyang YB, Lu Y, Yue S, Giffard RG. MiR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytes. Mitochondrion, 2012, 12(2): 213–219. <\p>

[9] Chen H, Chen Q, Fang M, Mi Y. MicroRNA-181b tar-gets MLK2 in HL-60 cells. Sci China Life Sci, 2010, 53(1): 101–106. <\p>

[10] Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu Z, You Y. Hsa- mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res, 2008, 1236: 185–193. <\p>

[11] Xu ZY, Jiang JF, Xu C, Wang Y, Sun L, Guo XC, Liu HQ. MicroRNA-181 regulates CARM1 and histone aginine methylation to promote differentiation of human embry-onic stem cells. PLoS ONE, 2013, 8(1): e53146. <\p>

[12] Torres-Padilla ME, Parfitt DE, Kouzarides T, Zernicka- Goetz M. Histone arginine methylation regulates pluripotency in the early mouse embryo. Nature, 2007, 445(7124): 214–218. <\p>

[13] Wu Q, Bruce AW, Jedrusik A, Ellis PD, Andrews RM, Langford CF, Glover DM, Zernicka-Goetz M. CARM1 is required in embryonic stem cells to maintain pluripotency and resist differentiation. Stem Cells, 2009, 27(11): 2637–2645. <\p>

[14] Kane NM, Howard L, Descamps B, Meloni M, McClure J, Lu R, McCahill A, Breen C, Mackenzie RM, Delles C, Mountford JC, Milligan G, Emanueli C, Baker AH. Role of microRNAs 99b, 181a, and 181b in the differentia-tion of human embryonic stem cells to vascular endo-thelial cells. Stem Cells, 2012, 30(4): 643–654. <\p>

[15] O'Loghlen A, Muñoz-Cabello AM, Gaspar-Maia A, Wu HA, Banito A, Kunowska N, Racek T, Pemberton HN, Beolchi P, Lavial F, Masui O, Vermeulen M, Carroll T, Graumann J, Heard E, Dillon N, Azuara V, Snijders AP, Peters G, Bernstein E, Gil J. MicroRNA regulation of Cbx7 mediates a switch of polycomb orthologs during ESC differentiation. Cell Stem Cell, 2012, 10(1): 33–46. <\p>

[16] Mintz PJ, Sætrom P, Reebye V, Lundbæk MB, Lao K, Rossi JJ, Gaensler KM, Kasahara N, Nicholls JP, Jensen S, Haoudi A, Emara MM, Gordon MY, Habib NA. MicroRNA- 181a* targets nanog in a subpopulation of CD34(+) cells isolated from peripheral blood. Mol Ther Nucleic Acids, 2012, 1: e34. <\p>

[17] Niwa H, Toyooka Y, Shimosato D, Strumpf D, Takahashi K, Yagi R, Rossant J. Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation. Cell, 2005, 123(5): 917–929. <\p>

[18] Zaehres H, Lensch MW, Daheron L, Stewart SA, Itskovitz- Eldor J, Daley GQ. High-efficiency RNA interference in hu-man embryonic stem cells. Stem Cells, 2005, 23(3): 299–305. <\p>

[19] Fong H, Hohenstein KA, Donovan PJ. Regulation of self-renewal andpluripotency by Sox2 in human embry-onic stem cells. Stem Cells, 2008, 26(8): 1931–1938. <\p>

[20] Li X, Zhang J, Gao L, McClellan S, Finan MA, Butler TW, Owen LB, Piazza GA, Xi Y. MiR-181 mediates cell dif-ferentiation by interrupting the Lin28 and let-7 feedback circuit. Cell Death Differ, 2012, 19(3): 378–386. <\p>

[21] Naguibneva I, Ameyar-Zazoua M, Polesskaya A, Ait-Si- Ali S, Groisman R, Souidi M, Cuvellier S, Harel-Bellan A. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol, 2006, 8(3): 278–284. <\p>

[22] Li YG, Zhang PP, Jiao KL, Zou YZ. Knockdown of microRNA-181 by lentivirus mediated siRNA expres-sion vector decreases the arrhythmogenic effect of skeletal myoblast transplantation in rat with myocardial infarction. Microvasc Res, 2009, 78(3): 393–404. <\p>

[23] Bhushan R, Grünhagen J, Becker J, Robinson PN, Ott CE, Knaus P. miR-181a promotes osteoblastic differentiation through repression of TGF-β signaling molecules. Int J Biochem Cell Biol, 2013, 45(3): 696–705. <\p>

[24] Liu G, Min H, Yue S, Chen CZ. Pre-miRNA loop nucleotides control the distinct activites of mir-181c in early T cell development. PLoS ONE, 2008, 3(10): e3592. <\p>

[25] Li QJ, Chau J, Ebert PJ, Sylvester G, Min H, Liu G, Braich R, Manoharan M, Soutschek J, Skare P, Klein LO, Davis MM, Chen CZ. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell, 2007, 129(1): 147–161. <\p>

[26] Fragoso R, Mao T, Wang S, Schaffert S, Gong X, Yue S, Luong R, Min H, Yashiro-Ohtani Y, Davis M, Pear W, Chen CZ. Modulating the strength and threshold of NOTCH oncogenic signals by mir-181a-1/b-1. PLoS Genet, 2012, 8(8): e1002855. <\p>

[27] Xue Q, Guo ZY, Li W, Wen WH, Meng YL, Jia LT, Wang J, Yao LB, Jin BQ, Wang T, Yang AG. Human activated CD4(+) T lymphocytes increase IL-2 expression by downregulating microRNA-181c. Mol Immunol, 2011, 48(4): 592–599. <\p>

[28] Frank C, Martin F, Valarie M, Steven RP, Ahmad AA, Charles TL, Jeffrey SM. Cutting edge: microRNA-181 promotes human NK cell development by regulating Notch signaling. J Immunol, 2011, 187(12): 6171–6175. <\p>

[29] Zi?tara N, ?yszkiewicz M, Witzlau K, Naumann R, Hurwitz R, Langemeier J, Bohne J, Sandrock I, Ballmaier M, Weiss S, Prinz I, Krueger A. Critical role for miR-181a/ b-1 in agonist selection of invariant natural killer T cells. Proc Natl Acad Sci USA, 2013, 110(18): 7407–7412. <\p>

[30] Henao-Mejia J, Williams A, Goff LA, Staron M, Licona- Limón P, Kaech SM, Nakayama M, Rinn JL, Flavell RA. The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lympho-cyte development and homeostasis. Immunity, 2013, 38(5): 984–997. <\p>

[31] Lashine YA, Seoudi AM, Salah S, Abdelaziz AI. Expres-sion signature of microRNA-181-a reveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosus. Clin Exp Rheumatol, 2011, 29(2): 351– 357. <\p>

[32] Wu C, Gong Y, Yuan J, Zhang W, Zhao G, Li H, Sun A, Hu K, Zou Y, Ge J. MicroRNA-181a represses ox-LDL- stimulated inflammatory response in dendritic cell by targeting c-Fos. J Lipid Res, 2012, 53(11): 2355–2363. <\p>

[33] Hutchison ER, Kawamoto EM, Taub DD, Lal A, Abdelmohsen K, Zhang Y, Wood WH, Lehrmann E, Camandola S, Becker KG, Gorospe M, Mattson MP. Evidence for miR-181 involvement in neuroinflammatory responses of astrocytes. Glia, 2013, 61(7): 1018–1028. <\p>

[34] Feng MJ, Shi F, Qiu C, Peng WK. MicroRNA-181a, -146a and -146b in spleen CD4+ T lymphocytes play proinflammatory roles in a murine model of asthma. Int Immunopharmacol, 2012, 13(3): 347–353. <\p>

[35] Guo XK, Zhang Q, Gao L, Li N, Chen XX, Feng WH. In-creasing expression of microRNA 181 inhibits porcine re-productive and respiratory syndrome virus replication and has implications for controlling virus infection. J Virol, 2013, 87(2): 1159–1171. <\p>

[36] Gao L, Guo XK, Wang L, Zhang Q, Li N, Chen XX, Wang Y, Feng WH. MicroRNA 181 suppresses porcine reproductive and respiratory syndrome virus (PRRSV) in-fection by targeting PRRSV receptor CD163. J Virol, 2013, 87(15): 8808–8812. <\p>

[37] Ji J, Yamashita T, Budhu A, Forgues M, Jia HL, Li C, Deng C, Wauthier E, Reid LM, Ye QH, Qin LX, Yang W, Wang HY, Tang ZY, Croce CM, Wang XW. Identifica-tion of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology, 2009, 50(2): 472–480. <\p>

[38] Ji J, Yamashita T, Wang XW. Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma. Cell Biosci, 2011, 1(1): 4–12. <\p>

[39] Meng F, Glaser SS, Francis H, DeMorrow S, Han Y, Passarini JD, Stokes A, Cleary JP, Liu X, Venter J, Kumar P, Priester S, Hubble L, Staloch D, Sharma J, Liu CG, Alpini G. Functional analysis of microRNAs in human hepatocellular cancer stem cells. J Cell Mol Med, 2012, 16(1): 160–173. <\p>

[40] Song MK, Park YK, Ryu JC. Polycyclic aromatic hydro-carbon (PAH)-mediated upregulation of hepatic microRNA- 181 family promotes cancer cell migration by targeting MAPK phosphatase-5, regulating the activation of p38 MAPK. Toxicol Appl Pharmacol, 2013, 273(1): 130–139. <\p>

[41] Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, Ghoshal K. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene, 2010, 29(12): 1787–1797. <\p>

[42] Zhang X, Nie Y, Du Y, Cao J, Shen B, Li Y. MicroRNA- 181a promotes gastric cancer by negatively regulating tumor suppressor KLF6. Tumour Biol, 2012, 33(5): 1589–1597. <\p>

[43] Chen L, Yang Q, Kong WQ, Liu T, Liu M, Li X, Tang H. MicroRNA-181b targets cAMP responsive element binding protein 1 in gastric adenocarcinomas. IUBMB Life, 2012, 64(7): 628–635. <\p>

[44] Neel JC, Lebrun JJ. Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells. Cell Signal, 2013, 25(7): 1556–1566. <\p>

[45] Guo LJ, Zhang QY. Decreased serum miR-181a is a po-tential new tool for breast cancer screening. Int J Mol Med, 2012, 30(3): 680–686. <\p>

[46] Nishimura J, Handa R, Yamamoto H, Tanaka F, Shibata K, Mimori K, Takemasa I, Mizushima T, Ikeda M, Sekimoto M, Ishii H, Doki Y, Mori M. microRNA-181a is associated with poor prognosis of colorectal cancer. Oncol Rep, 2012, 28(6): 2221–2226. <\p>

[47] Pichler M, Winter E, Ress AL, Bauernhofer T, Gerger A, Kiesslich T, Lax S, Samonigg H, Hoefler G. miR-181a is associated with poor clinical outcome in patients with co-lorectal cancer treated with EGFR inhibitor. J Clin Pathol, 2013, 4. <\p>

[Epub ahead of print] <\p>

[48] Lin S, Pan L, Guo S, Wu J, Jin L, Wang JC, Wang S. Prog-nostic role of microRNA-181a/b in hematological malig-nancies: a meta-analysis. PLoS ONE, 2013, 8(3): e59532.<\p>